Abstract |
Schwarz Pharma, under license from Harris FRC, is developing SPM-927, synthesized by researchers at the University of Houston, for the potential treatment of epilepsy and neuropathic pain.
|
Authors | Collin A Hovinga |
Journal | IDrugs : the investigational drugs journal
(IDrugs)
Vol. 6
Issue 5
Pg. 479-85
(May 2003)
ISSN: 1369-7056 [Print] England |
PMID | 12789603
(Publication Type: Journal Article, Review)
|
Chemical References |
- Amides
- Analgesics
- Anticonvulsants
- 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)-
- Propane
|
Topics |
- Amides
(chemistry, therapeutic use)
- Analgesics
(chemistry, therapeutic use)
- Animals
- Anticonvulsants
(chemistry, therapeutic use)
- Clinical Trials as Topic
(statistics & numerical data)
- Humans
- Propane
(analogs & derivatives, chemistry, therapeutic use)
- Technology, Pharmaceutical
(legislation & jurisprudence, methods)
|